Neurotransmitters in Multiple Sclerosis: Glutamate, GABA, Dopamine & Serotonin

Multiple sclerosis (MS) is an autoimmune disease attacking the central nervous system. While neurotransmitter involvement is an active research area, evidence suggests several key systems are disrupted.

Key Neurotransmitter Alterations in MS

Glutamate (Excitatory)

  • Primary excitatory neurotransmitter
  • Dysregulation → excitotoxicity → neuronal damage
  • Implicated in MS pathogenesis and symptom progression

GABA (Inhibitory)

  • Primary inhibitory neurotransmitter
  • Reduced levels observed in MS patients
  • Imbalance contributes to hyperexcitability and neurodegeneration

Dopamine

  • Involved in movement, reward, motivation
  • Reduced levels in certain brain regions
  • May contribute to fatigue, coordination issues, mood disturbances

Serotonin

  • Regulates mood, sleep, appetite
  • Altered levels in MS
  • May underlie high rates of depression and anxiety in MS

Therapeutic Implications

Research explores drugs targeting glutamate modulation (e.g., riluzole) and dopamine enhancement. However, neurotransmitter-based therapies remain investigational. Current MS treatments focus on immunomodulation.

Understanding neurotransmitter dynamics may yield future symptomatic and neuroprotective treatments.

Multiple Sclerosis - Related Articles